Has Jesse Sethi received payments from drug or device companies?

Yes. Drug and device makers reported $150,285 in general payments to Jesse Sethi across 278 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jesse Sethi did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jesse Sethi come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jesse Sethi

Cardiovascular Disease · Phoenix, AZNPI 1528033917

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $144,353 of the $150,285 with a category attached, or 96.1%. Abbott accounts for 99.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $70,896 and has fallen 99.9% since, to $99 in 2025. Among cardiovascular disease clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$150,285in general payments, 2019–2025

Across 278 payments — averaging $540.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$149K
Boston Scientific$456
Medtronic$145
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$109
Bardy Diagnostics, Inc.$45
Actelion Pharmaceuticals US, Inc.$29
plus $18 from 1 others

What the payments were for

Consulting fees$144,35396%
Food & beverage$5,7944%
Education$1390%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	264	$149,483
Boston Scientific	5	$456
Medtronic	1	$145
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$109
Bardy Diagnostics, Inc.	3	$45
Actelion Pharmaceuticals US, Inc.	1	$29
Novartis	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$150,285 in reported general payments places this provider in the 95th percentile of 423 cardiovascular disease providers in Arizona.

See all cardiovascular disease providers in Arizona →

Other cardiovascular disease in Phoenix

Ashish GuptaPhoenix$1.1M
Rajkumar SugumaranPhoenix$957K
Tabitha MoePhoenix$182K
Robert ScottPhoenix$106K
Kethes WaramPhoenix$66K
Ayman JamalPhoenix$42K
Sarika DesaiPhoenix$41K
Suzanne SorofPhoenix$29K
Namit RohantPhoenix$25K
Venkataramanan GangadharanPhoenix$23K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →